70 results
8-K
EX-99.1
NGNE
Neurogene Inc
22 Apr 24
Neurogene Announces Upcoming Presentation of Safety Data from Phase 1/2 Trial of NGN-401 Gene Therapy for Rett Syndrome at ASGCT Meeting
4:44pm
discuss goals, intentions and expectations as to future plans, trends, events, results of operations or financial condition, or otherwise, based
8-K
EX-99.1
NGNE
Neurogene Inc
18 Mar 24
Neurogene Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Updates
4:10pm
statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may discuss goals, intentions and expectations
8-K
EX-99.2
NGNE
Neurogene Inc
4 Mar 24
Neurogene Announces Expansion and Plans for More Rapid Patient Enrollment of Rett
7:30am
the meaning of the Private Securities Litigation Reform Act of 1995. These statements may discuss goals, intentions and expectations as to future plans
8-K
EX-99.1
6nqvppnn 4egzn05yg
4 Mar 24
Neurogene Announces Expansion and Plans for More Rapid Patient Enrollment of Rett
7:30am
S-8
EX-99.2
jtk6pr
20 Feb 24
Registration of securities for employees
4:16pm
8-K
EX-99.2
tn94ui4wy zdhn6j8
5 Jan 24
Neurogene Announces Business Update and 2024 Outlook
7:11am
8-K
EX-99.1
08ov ijdcizclybjl
5 Jan 24
Neurogene Announces Business Update and 2024 Outlook
7:11am
8-K
EX-99.2
xofig b45ah3o
19 Dec 23
Neurogene Doses First Patients in Phase 1/2 Trial of NGN-401 for the Treatment of Female Pediatric Patients with Rett Syndrome
7:31am
8-K
EX-10.21
dg90ncqlp42
19 Dec 23
Neurogene Doses First Patients in Phase 1/2 Trial of NGN-401 for the Treatment of Female Pediatric Patients with Rett Syndrome
7:31am
8-K
las37u7
19 Dec 23
Neurogene Doses First Patients in Phase 1/2 Trial of NGN-401 for the Treatment of Female Pediatric Patients with Rett Syndrome
7:31am
8-K
EX-99.1
i2elw yciqx
19 Dec 23
Neurogene Doses First Patients in Phase 1/2 Trial of NGN-401 for the Treatment of Female Pediatric Patients with Rett Syndrome
7:31am
425
a4v64a qqamnb
6 Dec 23
Business combination disclosure
4:24pm
8-K
k336g
6 Dec 23
Other Events
4:21pm
425
2ycswzmudfnbd7vkqcwh
4 Dec 23
Business combination disclosure
5:14pm
8-K
1x5kg mx1us6x796v
4 Dec 23
Other Events
5:10pm
425
jtqz k4psh
30 Nov 23
Business combination disclosure
4:06pm